Natalie Thovmasian Promoted to Principal
Clarion is pleased to announce that Natalie Thovmasian has been promoted to Principal. Over the last five years, Natalie has helped fuel the consistent growth of Clarion’s oncology practice. In this role, Natalie has excelled as an early oncology asset specialist where she seamlessly blends her appreciation of the complexities in oncology technology innovation together with her intimate understanding of the practical requirements for an asset to deliver meaningful clinical benefit to patients.
“Natalie is an outstanding thought partner for developing strategies for oncology innovation,” reflected Dennis Chang, Managing Director and Clarion Oncology subject matter expert. “She is exceptionally capable of blending deeply analytic approaches with creative thinking to inspire our joint Clarion/client teams to see and create opportunity in this highly competitive and challenging space.”
Tom Murtagh, Clarion CEO and Founder adds, “In addition to her client work, Natalie has been an integral part of our advanced degree candidate recruiting—ensuring that we hire candidates that align with Clarion’s expertise and values. We are thrilled for her continued growth and development and her contributions to Clarion’s professional development model as a member of our Leadership Team.”
Prior to joining Clarion, Natalie was a member of the Business Development team at Boston Children’s Hospital in the Technology and Innovation Development Office. In this role, she helped create academic-private partnerships and propel the commercialization of intellectual property. Natalie received her PhD in Biological and Biomedical Sciences from Harvard University with a focus on cancer cell metabolism. She received her BS in Biochemistry from Creighton University.